Hormone Therapy

Hormone Therapy Advice for Medical Practitioners

Advice to medical practitioners regarding the use of postmenopausal hormone therapy

The Hormone Therapy advice statement was updated with input from prominent experts in the field including RANZCOG Fellows, The Australian Menopause Society and The Endocrine Society of Australia. This was approved by RANZCOG Council in July 2009. More ( 44 KB)

Hormone Therapy (HT)

Hormone Therapy Background

In response to reports commencing in 2002 on adverse response to HRT (HT - hormone therapy), below are links to the original JAMA article and a useful link to the Jean Hailes Foundation who provide a piece "Your questions answered" and a commentary on the article by Dr Rod Baber, President Menopause Society.

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women

Principal Results From the Women's Health Initiative Randomized Controlled Trial, Writing Group for the Women's Health Initiative Investigators, JAMA. 2002; 288: 321-333.

Read an abstract of the original JAMA article

Jean Hailes Foundation - Hormone Therapy (HT)

The Jean Hailes Foundation is a not-for-profit organisation whose team of researchers, clinicians and educators translates the research findings into practical health information for women and health professionals.

The Foundation's HT page has information on HT research and resources on the risks / benefits and side effects of HT.

View the Jean Hailes Foundation Hormone Therapy (HT) page

Australian Menopause Society

Read the Australian Menopause Society's response to the JAMA article

TGA Report

Report of Expert Committee Convened by the Therapeutic Goods Administration to assess the findings of a report on the safety of the US Women's Health Initiative (combined Hormone Replacement Therapy) trial, 11 July 2002

TGA Report of Expert Committee on the U.S. HRT trial ( 41 KB)

© RANZCOG